PA
Paranovus Entertainment Technology Ltd.
PAVS · NASDAQ
$3.77 +0.53% (+$0.02)
1M -18.12%
Market Cap $3.21M
P/E Ratio -
Div. Yield -
ROE 46.69%
Bulios Fair Price
$5.46
44.8% upside
Current Price
$3.77
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PAVS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.10x
P/S 0.22x
EV/EBITDA N/A
Growth
22 /100
Declining Book val. growth 28.41%
Rev. growth 14.46%
FCF growth N/A
Profitability
4 /100
Weak Net margin 87.20%
Op. margin 23.11%
FCF margin 9.59%
Quality
5 /100
Poor ROE 46.69%
ROA 34.54%
Asset turnover 0.40x
Debt
69 /100
Low Current ratio 8.18x
Int. coverage -54.14x
Debt/Equity 0.02x
Stability
13 /100
Unstable Rev. volatility 11,775.84%
EPS volatility 1,355.58%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PAVS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Xiaoyue Zhang
Employees
29
Headquarters
New York
Upcoming events
15 JAN
Earnings
Upcoming earnings report